The PE ratio for Chemed stock stands at 23.25 as of Jun 3, 2026. The calculation is based on the latest EPS of $18.36 and the stock price of $426.86 per share. The PE ratio currently is comparable to its last four-quarter average.
Over the last ten years, the average PE ratio of Chemed has been 28.85. The current 23.25 P/E ratio is 19% lower than the historical average. Looking back at the last ten years, CHE's PE ratio peaked in the Jun 2017 quarter at 49.52, with a price of $204.53 and an EPS of $4.13. The Mar 2026 quarter marked the lowest point at 20.57, with a price of $377.74 and an EPS of $18.36.
Maximum annual increase: 64.61% in 2017
Maximum annual decrease: -44.36% in 2018
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 23.23 | -11.87% | $427.86 | $18.42 |
| 2024 | 26.36 | -18.36% | $529.8 | $20.1 |
| 2023 | 32.29 | 5.76% | $584.75 | $18.11 |
| 2022 | 30.53 | -1.1% | $510.43 | $16.72 |
| 2021 | 30.87 | 16.05% | $529.04 | $17.14 |
| 2020 | 26.6 | -16.61% | $532.61 | $20.02 |
| 2019 | 31.9 | 44.15% | $439.26 | $13.77 |
| 2018 | 22.13 | -44.36% | $283.28 | $12.8 |
| 2017 | 39.77 | 64.61% | $243.02 | $6.11 |
| 2016 | 24.16 | 5.46% | $160.41 | $6.64 |
| 2015 | 22.91 | 25.53% | $149.8 | $6.54 |
| 2014 | 18.25 | 1% | $105.67 | $5.79 |
| 2013 | 18.07 | 24.36% | $76.62 | $4.24 |
| 2012 | 14.53 | 18.9% | $68.59 | $4.72 |
| 2011 | 12.22 | -30.33% | $51.21 | $4.19 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 20.57 | -11.45% | $377.74 | $18.36 |
| Dec 2025 | 23.23 | -1.27% | $427.86 | $18.42 |
| Sep 2025 | 23.53 | -5.24% | $447.74 | $19.03 |
| Jun 2025 | 24.83 | -16.43% | $486.93 | $19.61 |
| Mar 2025 | 29.71 | 12.71% | $615.32 | $20.71 |
| Dec 2024 | 26.36 | -12.22% | $529.8 | $20.1 |
| Sep 2024 | 30.03 | 10.36% | $600.97 | $20.01 |
| Jun 2024 | 27.21 | -20.39% | $542.58 | $19.94 |
| Mar 2024 | 34.18 | 5.85% | $641.93 | $18.78 |
| Dec 2023 | 32.29 | 1.29% | $584.75 | $18.11 |
| Sep 2023 | 31.88 | -10.83% | $519.7 | $16.3 |
| Jun 2023 | 35.75 | 6.78% | $541.67 | $15.15 |
| Mar 2023 | 33.48 | 9.66% | $537.75 | $16.06 |
| Dec 2022 | 30.53 | 21.83% | $510.43 | $16.72 |
| Sep 2022 | 25.06 | -2.72% | $436.56 | $17.42 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
CHE's current PE ratio is lower than its 3, 5 and 10-year averages.
Chemed's price to earnings (P/E) of 23.25 is higher than the Healthcare sector and the industry average. But in comparison with the Healthcare sector average of 23.02, Chemed's price to earnings (P/E) is only 1% higher.
In comparison to its peers BCPC and SXT, CHE's PE ratio is lower, but it is higher than RPM's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| RPM Rpm International Inc | 20 | $13.3B |
| CHE Chemed Corp | 23.55 | $5.74B |
| BCPC Balchem Corp | 32.1 | $5.07B |
| SXT Sensient Technologies Corp | 33.18 | $4.8B |
As of Jun 3, 2026, CHE stock has a price to earnings ratio of 23.25.
As an average over the last 3 years, CHE stock has a PE ratio of 28.3.
As an average over the last 5 years, CHE stock has a PE ratio of 28.17.
Over the last ten years, the quarterly PE ratio reached its highest level at 49.52 in the Jun 2017 quarter.
CHE's current price to earnings ratio is 19% below its 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 3, 2026), Chemed's share price is $426.86. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $18.36. Therefore, Chemed's PE ratio for today is 23.25. PE RATIO(23.25) = STOCK PRICE($426.86) / TTM EPS($18.36)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.